Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Jun;84(3):812-821.
doi: 10.1007/s12020-024-03688-5. Epub 2024 Jan 24.

Prognostic role and characteristics of the indeterminate response in differentiated thyroid cancer: a systematic review

Affiliations

Prognostic role and characteristics of the indeterminate response in differentiated thyroid cancer: a systematic review

P Bellini et al. Endocrine. 2024 Jun.

Abstract

Purpose: The management of differentiated thyroid cancer (DTC) is actually based on a dynamic risk stratification based on classes of response to the therapy. Indeterminate response (IR) includes a heterogeneous group of patients with different characteristics, particularly different Tg and AbTg levels and/or imaging findings. The aim of systematic review (SR) is to evaluate the prognosis, diagnostic findings and other characteristics of patients in the IR class.

Methods: A wide literature search in the Scopus, PubMed/MEDLINE and Web of Science databases was performed to find published articles on patients with DTC and IR after treatment. The quality assessment of studies was carried out using QUADAS-2 evaluation.

Results: Eight articles were included in the systematic review. Six studies evaluated the prognosis and the prognostic factor in patients with IR, one study evaluated the role of 2-[18F]FDG PET-CT in the management of patients with IR and biochemical incomplete response and one study the risk factors for IR.

Conclusion: Patients with DTC and IR to therapy have a probability of disease relapse < 15%. Tg value could be a predictor of disease progression. The role of 2-[18F]FDG PET-CT needs to be further investigated.

Keywords: Indeterminate response; Systematic review; Thyroid cancer.

PubMed Disclaimer

References

    1. D. Albano, F. Dondi, P. Bellini, F. Bertagna, Biomarkers and Molecular Imaging in Postoperative DTC Management. In: Giovanella, L. (eds) Integrated Diagnostics and Theranostics of Thyroid Diseases (Springer, Cham, 2023), https://doi.org/10.1007/978-3-031-35213-3_8
    1. M.E. Cabanillas, D.G. McFadden, C. Durante, Thyroid cancer. Lancet 388(10061), 2783–2795 (2016). https://doi.org/10.1016/S0140-6736(16)30172-6 - DOI - PubMed
    1. S. Filetti, C. Durante, D. Hartl, S. Leboulleux, L.D. Locati, K. Newbold, M.G. Papotti, A. Berruti, ESMO Guidelines Committee. Electronic address: clinicalguidelines@esmo.org. Thyroid cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up†. Ann. Oncol. 30(12), 1856–1883 (2019). https://doi.org/10.1093/annonc/mdz400 - DOI - PubMed
    1. E.F.S. van Velsen, R.P. Peeters, M.T. Stegenga, F.J. van Kemenade, T.M. van Ginhoven, M. van Balkum, F.A. Verburg, W.E. Visser, Evaluating Disease-specific Survival Prediction of Risk Stratification and TNM Systems in Differentiated Thyroid Cancer. J. Clin. Endocrinol. Metab. 108(6), e267–e274 (2023). https://doi.org/10.1210/clinem/dgac721 - DOI - PubMed
    1. B.R. Roman, L.G. Morris, L. Davies, The thyroid cancer epidemic, 2017 perspective. Curr. Opin. Endocrinol. Diabetes Obes. 24(5), 332–336 (2017). https://doi.org/10.1097/MED.0000000000000359 - DOI - PubMed - PMC

Publication types

LinkOut - more resources